Biostatistics Shared Resources Core
生物统计学共享资源核心
基本信息
- 批准号:9883738
- 负责人:
- 金额:$ 86.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-01 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:Acute Lymphocytic LeukemiaAdherenceAffectAnusBasic ScienceBig DataBiologicalBiometryBiostatistics Shared ResourceBloodBone DensityBone Mineral ContentsCancer Center Support GrantCancer ControlChildChildhood Acute Lymphocytic LeukemiaClinical InvestigatorClinical OncologyClinical ResearchClinical TrialsClinical assessmentsCollaborationsComplexComputer SystemsComputer softwareConsultConsultationsDataData AnalysesDepartment chairDevelopmentDiagnosisDisease MarkerDoseDrug KineticsEducational StatusEducational workshopEnrollmentEnsureFacultyFollow-Up StudiesFrequenciesFundingGenesGeneticGenetic MarkersGenomicsGoalsGrowthImmunotherapyInformation ServicesInfrastructureJournalsLaboratoriesLate EffectsLife Cycle StagesMalignant Childhood NeoplasmMalignant NeoplasmsMeasuresMethodologyMethodsMissionMolecularMotivationMutationNatureNeuropathyNewly DiagnosedOncologyOutcomePaperPatientsPhysical FunctionPhysical activityPhysical therapyPopulationProcessPublicationsQuality of lifeRadiation exposureRadiology SpecialtyRandomizedRemission InductionResearchResearch DesignResearch PersonnelResearch Project GrantsResidual NeoplasmResource SharingRiskSaint Jude Children&aposs Research HospitalScientific Advances and AccomplishmentsSeveritiesSurvivorsSystemTherapeuticTherapeutic InterventionTimeTranslatingUnited StatesUpdateVincristineWorkanticancer researchbasecancer clinical trialcohortdesigndisorder subtypeelectronic data capture systemexercise intensityexperienceimprovedindexinglecturesleukemia treatmentmedulloblastomamembermulti-site trialneurotoxicitypersonalized medicineprecision medicineprogramsrecruitrelapse risksoundsurvivorshiptranslational scientisttreatment as usual
项目摘要
PROJECT SUMMARY/ABSTRACT— Biostatistics Shared Resource
The Biostatistics Shared Resource (BSR) is a SJCCC managed shared resource with the overarching mission
of impacting pediatric cancer through biostatistics collaboration and consulting, and through comprehensive,
effective, and timely biostatistical support to Center members. BSR has a highly experienced and interactive
team of biostatisticians who work collaboratively with researchers who are conducting leading edge basic
science, clinical research, and population and survivorship research from the 5 SJCCC Programs. This is
evidenced by the high level of collaborative publications and key scientific contributions in high-impact journals
such as Journal of Clinical Oncology (n=31), Cancer (n=31), Nature Genetics (n=9), and Lancet Oncology (n=4).
In addition, BSR biostatisticians are well integrated into the clinical trial teams providing statistical support
throughout the life cycle of the research project from concept development through publication. During the last
funding period, 85% of all SJCCC publications used the BSR and 77% (n=358/468) of all collaborative
publications with a biostatistician as a co-author were associated with SJCCC programs. These included papers
from all 5 of the programs: CCSP (n = 103), CBP (n = 1), DBSTP (n = 66), NBTP (n = 83), and HMP (n = 105).
A total of 125 St. Jude investigators and their staff used the BSR during the index year (FY2017). Of those, 71
(57%) were SJCCC members. The BSR faculty also offer workshops, office consultations, lectures, seminars,
Grand Rounds, and courses on study design, analysis methods, and software implementation to fellows,
research staff, and faculty. The BSR is led by Dr. Deo Kumar Srivastava who has more than 23 years'
experience in the statistical design and analysis of cancer research and cancer clinical trials. He is supported by
9 faculty biostatisticians and 13 master's-level trained staff, ensuring that BSR support is available to
investigators throughout all 5 programs. During our most recent funding period, BSR has witnessed growth
driven by the strengthening of the scientific programs, research in genomic characterization of pediatric cancers,
and focus on complex precision medicine SJCCC investigator-initiated multisite trials. Goals for the next funding
period include continuing to provide state-of-the-art statistical support to all SJCCC investigators including new
investigators, and targeted recruitment of biostatisticians to strengthen expertise in personalized medicine,
immunotherapy, and in expansion of high-throughput big data. Lastly, BSR will closely partner with the
Information Services department in the implementation of the new software provided by the Clinical Trials
Management System.
项目摘要/摘要 - 生物统计学共享资源
生物统计学共享资源(BSR)是带有总体任务的SJCCC托管共享资源
通过生物统计学合作和咨询来影响小儿癌,以及通过全面的
对中心成员有效,及时的生物统计支持。 BSR具有经验丰富且互动的
生物统计学家团队与正在领先基本的研究人员合作
来自5个SJCCC计划的科学,临床研究以及人口以及生存研究。这是
高水平的合作出版物和高影响力期刊的关键科学贡献所证明
例如临床肿瘤学期刊(n = 31),癌症(n = 31),自然遗传学(n = 9)和柳叶刀肿瘤学(n = 4)。
此外,BSR生物统计学家已很好地整合到提供统计支持的临床试验团队中
在整个研究项目的整个生命周期中,从概念开发到出版。最后
资金期,所有SJCCC出版物中有85%使用BSR,所有协作中的77%(n = 358/468)
与生物统计学家作为合着者的出版物与SJCCC计划有关。这些包括论文
从所有5个程序中:CCSP(n = 103),CBP(n = 1),DBSTP(n = 66),NBTP(n = 83)和HMP(n = 105)。
在指数年(2017财年),共有125名圣裘德调查员及其工作人员使用了BSR。其中71
(57%)是SJCCC成员。 BSR教职员工还提供讲习班,办公室咨询,讲座,半手
大回合以及研究设计,分析方法和软件实施的课程,
研究人员和教师。 BSR由拥有23年以上的Deo Kumar Srivastava博士领导
癌症研究和癌症临床试验的统计设计和分析经验。他得到了
9位教师生物统计学家和13名师父训练有素的员工,以确保BSR支持可供您使用
整个5个计划的调查人员。在我们最近的资金期间,BSR目睹了增长
在加强科学计划的驱动下,小儿癌基因组表征的研究,
并专注于复杂的精密医学SJCCC研究者发起的多站点试验。下一个资金的目标
期间包括继续向所有SJCCC调查人员提供最先进的统计支持
调查人员并针对招募生物统计学家来增强个性化医学专业知识,
免疫疗法,并扩大高通量大数据。最后,BSR将与
信息服务部在实施临床试验提供的新软件
管理系统。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MOTOMI MORI其他文献
MOTOMI MORI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MOTOMI MORI', 18)}}的其他基金
IMPLICATIONS OF HLA POLYMORPHISM FOR DONOR RECRUITMENT
HLA 多态性对捐赠者招募的影响
- 批准号:
2901242 - 财政年份:1996
- 资助金额:
$ 86.36万 - 项目类别:
IMPLICATIONS OF HLA POLYMORPHISM FOR DONOR RECRUITMENT
HLA 多态性对捐赠者招募的影响
- 批准号:
2234923 - 财政年份:1996
- 资助金额:
$ 86.36万 - 项目类别:
IMPLICATIONS OF HLA POLYMORPHISM FOR DONOR RECRUITMENT
HLA 多态性对捐赠者招募的影响
- 批准号:
2685483 - 财政年份:1996
- 资助金额:
$ 86.36万 - 项目类别:
相似国自然基金
坚持还是转型?反馈驱动的创业者机会信念认知更新及响应决策机理
- 批准号:
- 批准年份:2022
- 资助金额:45 万元
- 项目类别:面上项目
坚持还是转型?反馈驱动的创业者机会信念认知更新及响应决策机理
- 批准号:72272131
- 批准年份:2022
- 资助金额:45.00 万元
- 项目类别:面上项目
不确定性下创业团队能量和抗逆力对创业坚持的权变影响研究
- 批准号:72162025
- 批准年份:2021
- 资助金额:29 万元
- 项目类别:地区科学基金项目
创造性思维中灵活性和坚持性动态交互的神经基础
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
创造性思维中灵活性和坚持性动态交互的神经基础
- 批准号:32100850
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
相似海外基金
FAACS: Feasibility/Acceptability of Attentional-Control Training in Survivors
FAACS:幸存者注意力控制训练的可行性/可接受性
- 批准号:
10458355 - 财政年份:2022
- 资助金额:
$ 86.36万 - 项目类别:
FAACS: Feasibility/Acceptability of Attentional-Control Training in Survivors
FAACS:幸存者注意力控制训练的可行性/可接受性
- 批准号:
10684249 - 财政年份:2022
- 资助金额:
$ 86.36万 - 项目类别:
Using Real Time Mobile Health Approaches to Understand and Promote Oral Chemotherapy Adherence in Adolescents and Young Adults with Leukemia
使用实时移动健康方法来了解和促进患有白血病的青少年和年轻人的口服化疗依从性
- 批准号:
10703839 - 财政年份:2022
- 资助金额:
$ 86.36万 - 项目类别:
Using Real Time Mobile Health Approaches to Understand and Promote Oral Chemotherapy Adherence in Adolescents and Young Adults with Leukemia
使用实时移动健康方法来了解和促进患有白血病的青少年和年轻人的口服化疗依从性
- 批准号:
10688202 - 财政年份:2022
- 资助金额:
$ 86.36万 - 项目类别:
COVID Extension: Material Hardship as a Targetable Measure of Poverty in Pediatric Cancer
COVID 扩展:物质困难作为小儿癌症贫困的有针对性的衡量标准
- 批准号:
10451029 - 财政年份:2021
- 资助金额:
$ 86.36万 - 项目类别: